Vaccination with long NY-ESO-1 79-108 peptide and CpG-B leads to robust activation of CD4 and CD8 T cell responses in stage III/IV melanoma patients, and a new HLA-DR7 epitope.
| Image |  |
|---|---|
| Description | scientific article published on 4 November 2015 |
| Author/s |
author: Camilla Jandus Olivier Michielin |
| Publication date | November 4, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |